Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. TxGNN is the first AI model specifically developed to identify ...

Algorithms used for consumer predictions are being retooled to help identify which medicines are optimal and may carry hidden risks for patients. Researchers from Monash University used a different ...

Using machine learning and a large volume of data on genes and existing drugs, researchers at Lund University in Sweden have identified a combination of statins and phenothiazines that is particularly ...

Old drugs, new ideas. That’s one of the core drivers of using artificial intelligence (AI) for drug development. Researchers using complex AI-fueled methods are now taking aim at what has become a ...

Understanding and preventing drug side effects holds a profound influence on drug development and utilization, profoundly impacting patients’ physical and mental well-being. Traditional artificial ...